Evidence map›Paper›PMID 36788590›Full record

ArticleStem cell research & therapy2023

Endothelial colony forming cell administration promotes neurovascular unit development in growth restricted and appropriately grown fetal lambs.

Alexander Bell, Ashalyn P Watt, Ingrid Dudink, Yen Pham, Amy E Sutherland, Beth J Allison, Courtney A McDonald, Margie Castillo-Melendez, Graham Jenkin, Atul Malhotra and 2 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Alexander BellThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia.
Ashalyn P WattThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia.
Ingrid DudinkThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia.
Yen PhamThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia.
Amy E SutherlandThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia.
Beth J AllisonThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia.
Courtney A McDonaldThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia.
Margie Castillo-MelendezThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia.
Graham JenkinThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia.
Atul MalhotraThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia. atul.malhotra@monash.edu.ORCID 0000-0001-9664-4182
Suzanne L Miller *The Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia.
Tamara Yawno *The Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Australia.
Hudson Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFetal growth restriction (FGR) is associated with deficits in the developing brain, including neurovascular unit (NVU) dysfunction. Endothelial colony forming cells (ECFC) can mediate improved vascular stability, and have demonstrated potential to enhance vascular development and protection. This investigation examined whether ECFCs from human umbilical cord blood (UCB) enhanced NVU development in FGR and appropriate for gestational age (AGA) fetal sheep.

methodsTwin-bearing ewes had surgery performed at 88-90 days' gestation, inducing FGR in one fetus. At 113 days, ECFCs (1 × 10

resultsTwenty-four fetal lambs, arranged in four groups: AGA (n = 7), FGR (n = 5), AGA + ECFC (n = 6), and FGR + ECFC (n = 6), were included in analyses. FGR resulted in lower body weight than AGA (P = 0.002) with higher brain/body weight ratio (P = 0.003). ECFC treatment was associated with increased vascular density throughout the brain in both AGA + ECFC and FGR + ECFC groups, as well as increased vascular-astrocyte coverage and VEGF expression in the cortex (P = 0.003, P = 0.0006, respectively) and in the subcortical white matter (P = 0.01, P = 0.0002, respectively) when compared with the untreated groups.

conclusionsECFC administration enhanced development of NVU components in both the AGA and FGR fetal brain. Further investigation is required to assess how to optimise the enhanced angiogenic capabilities of ECFCs to provide a therapeutic strategy to protect the developing NVU against vulnerabilities associated with FGR.

Indexed as

BrainBrain InjuriesAnimalsAnimals, NewbornBody WeightFemaleFetal BloodFetal Growth RetardationFetusHumansSheepBlood brain barrierBrain injuryCord bloodECFCEndothelial progenitor cellsFGRRepairStem cells

Identifiers

PMID36788590
PMCPMC9930266
OpenAlexW4320725515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.